beta-hydroxyisovalerylshikonin has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahina, Y; Hashiba, T; Hayashi, T; Honda, M; Kaneko, S; Nio, K; Nishitani, M; Okada, H; Suda, T; Sugimoto, S; Takatori, H; Yamashita, T | 1 |
1 other study(ies) available for beta-hydroxyisovalerylshikonin and Liver Neoplasms
| Article | Year |
|---|---|
Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Fluorouracil; Humans; Liver Neoplasms; Neoplastic Stem Cells | 2023 |